This review looked at how doctors have improved their ability to diagnose congenital adrenal hyperplasia (CAH) using genetic tests. Researchers analyzed the history of these tests, moving from older methods to modern ones like short-read and long-read next-generation sequencing. The goal was to understand which tools work best for finding the specific gene changes that cause this condition.
The analysis showed that short-read sequencing has limitations when trying to read complex parts of the gene involved in CAH. In contrast, long-read sequencing performed very well. It matched standard methods completely and successfully found genetic rearrangements that previous tests could not see. This suggests long-read technology is becoming a strong reference tool for high-resolution genetic testing.
Integrating these molecular tests into newborn screening programs appears to help reduce false alarms and speed up care for babies at risk. While the review suggests these new tools are reshaping clinical practice and guiding personalized treatment plans, the study did not report any safety concerns or side effects. Readers should note that because this was a review of existing data rather than a new clinical trial, the findings reflect current technical capabilities but do not replace individual medical advice.